Prot# GS-US-402-1852: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Subjects with Nonalcoholic Steatohepatitis (NASH)

Project: Research project

Project Details

StatusFinished
Effective start/end date11/15/1611/15/19

Funding

  • PRA Health Sciences (Prot# GS-US-402-1852)
  • Gilead Sciences, Inc. (Prot# GS-US-402-1852)